Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
NEDL1
(NEDD4-like ubiquitin protein ligase-1) is a newly identified HECT-type E3 ubiquitin protein ligase highly expressed in favorable neuroblastomas as compared with unfavorable ones. In this study, we found that
NEDL1
cooperates with p53 to induce apoptosis. During cisplatin (CDDP)-mediated apoptosis in
neuroblastoma
SH-SY5Y cells, p53 was induced to accumulate in association with an increase in expression levels of
NEDL1
. Enforced expression of
NEDL1
resulted in a decrease in number of G418-resistant colonies in SH-SY5Y and U2OS cells bearing wild-type p53, whereas
NEDL1
had undetectable effect on p53-deficient H1299 and SAOS-2 cells. Similarly, enforced expression of
NEDL1
increased number of U2OS cells with sub-G1 DNA content. Co-immunoprecipitation and in vitro binding assays revealed that
NEDL1
binds to the COOH-terminal region of p53. Luciferase reporter assay showed that
NEDL1
has an ability to enhance the transcriptional activity of p53. Small interfering RNA-mediated knockdown of the endogenous
NEDL1
conferred the resistance of U2OS cells to adriamycin. It is noteworthy that
NEDL1
enhanced pro-apoptotic activity of p53 in its catalytic activity-independent manner. Taken together, our present findings suggest that functional interaction of
NEDL1
with p53 might contribute to the induction of apoptosis in cancerous cells bearing wild-type p53.
...
PMID:A novel HECT-type E3 ubiquitin protein ligase NEDL1 enhances the p53-mediated apoptotic cell death in its catalytic activity-independent manner. 1822 81